4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic Acid丨CAS 641569-94-0

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid is primarily used as an advanced pharmaceutical research intermediate, particularly in the development of small-molecule compounds targeting kinase-related biological pathways. Its heteroaromatic framework and functional substituents make it valuable in medicinal chemistry programs focused on signal transduction, cell regulation, and modulation of disease-relevant enzymes. Researchers frequently employ this compound in structure–activity relationship studies, lead optimization, and the synthesis of candidate molecules with potential therapeutic relevance. Its stability and compatibility with common coupling strategies allow it to be incorporated efficiently into complex molecular architectures for laboratory investigations.

The compound offers several advantages to research teams, including a well-defined structure that facilitates predictable reactivity and efficient synthetic transformations. Its molecular features support diverse derivatization options, enabling broad adaptability for medicinal chemistry workflows. The compound's balanced polarity and aromatic components also contribute to favorable handling properties, allowing researchers to obtain consistent results when integrating it into multistep syntheses. These characteristics help streamline experimental planning, accelerate project timelines, and improve overall reproducibility in discovery-oriented work.